Otsuka Holdings Co (STU:OS1) ROCE %: 15.14% (As of Mar. 2026)


STU:OS1 Otsuka Holdings Co Ltd STU:OS1
86 GF Score
Price €58.50
GF Value €45.23
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Otsuka Holdings Co ROCE %?

Otsuka Holdings Co STU:OS1 +2.63% 86 ROCE % is 15.14% as of Mar. 2026. GuruFocus rates STU:OS1 with a GF Score™ of 86/100 and a GF Value™ of €45.23 (Modestly Overvalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Otsuka Holdings Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 15.14%.

Otsuka Holdings Co  (STU:OS1) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Otsuka Holdings Co ROCE % Related Terms

Otsuka Holdings Co ROCE % Historical Data

* Premium members only.

The historical data trend for Otsuka Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otsuka Holdings Co ROCE % Chart

Otsuka Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.32 6.91 5.41 11.74 14.21

Otsuka Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.67 15.82 20.64 9.01 15.14
STU:OS1
86GF Score
Otsuka Holdings Co Ltd STU:OS1
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otsuka Holdings Co ROCE % Calculation

Otsuka Holdings Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=2711.668/( ( (23216.207 - 3928.075) + (22991.489 - 4103.144) )/ 2 )
=2711.668/( (19288.132+18888.345)/ 2 )
=2711.668/19088.2385
=14.21 %

Otsuka Holdings Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=2884.06/( ( (22991.489 - 4103.144) + (22944.868 - 3740.102) )/ 2 )
=2884.06/( ( 18888.345 + 19204.766 )/ 2 )
=2884.06/19046.5555
=15.14 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 15.14% mean?
Otsuka Holdings Co (STU:OS1) has a ROCE % of 15.14% as of Mar. 2026.
Is Otsuka Holdings Co's ROCE % too high?
Otsuka Holdings Co's current ROCE % is 15.14%. The Drug Manufacturers industry median ROCE % is 7.00. Otsuka Holdings Co's value of 15.14% is 116.4% above this industry median. Overall, Otsuka Holdings Co has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's ROCE % compare to LLY and JNJ?
Otsuka Holdings Co's ROCE % of 15.14% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Otsuka Holdings Co's value of 15.14% is 116.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Otsuka Holdings Co's current ROCE % of 15.14% is 116.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Otsuka Holdings Co's current ROCE % is 15.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Otsuka Holdings Co (STU:OS1) is currently considered Modestly Overvalued. The stock's GF Value™ is €45.23, compared to a current price of €58.50 — trading 29.3% above its estimated fair value. The current ROCE % is 15.14% and 116.4% above the Drug Manufacturers industry median of 7.00. Otsuka Holdings Co's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Otsuka Holdings Co (STU:OS1), the current ROCE % is 15.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Otsuka Holdings Co (STU:OS1) Overvalued in 2026?

Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued. The current stock price of €58.50 is trading 29.3% above its estimated GF Value™ of €45.23. GuruFocus considers Otsuka Holdings Co to be Modestly Overvalued.

Key valuation signals for STU:OS1:

  • ROCE %: 15.14%
  • GF Value™: €45.23 vs. price of €58.50 (29.3% above fair value)
  • GF Score™: 86/100 with 1 warning sign
  • Industry Position: 116.4% above the Drug Manufacturers median

No single metric tells the full story. See the STU:OS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Otsuka Holdings Co Business Description

Address 2-16-4 Konan, Shinagawa Grand Central Tower, Minato-ku, Tokyo, JPN, 108-8241
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
86GF Score

Get the complete analysis for STU:OS1

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€58.50
Price
€45.23
GF Value